427 related articles for article (PubMed ID: 18174292)
41. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET.
Héroux M; Breton B; Hogue M; Bouvier M
Biochemistry; 2007 Jun; 46(23):7022-33. PubMed ID: 17503773
[TBL] [Abstract][Full Text] [Related]
42. Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion.
Keleg S; Kayed H; Jiang X; Penzel R; Giese T; Büchler MW; Friess H; Kleeff J
Int J Cancer; 2007 Jul; 121(1):21-32. PubMed ID: 17290391
[TBL] [Abstract][Full Text] [Related]
43. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
44. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
Fraser NJ; Wise A; Brown J; McLatchie LM; Main MJ; Foord SM
Mol Pharmacol; 1999 Jun; 55(6):1054-9. PubMed ID: 10347248
[TBL] [Abstract][Full Text] [Related]
45. Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin.
Fukai N; Shichiri M; Ozawa N; Matsushita M; Hirata Y
Endocrinology; 2003 Feb; 144(2):447-53. PubMed ID: 12538603
[TBL] [Abstract][Full Text] [Related]
46. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy.
Nagae T; Mukoyama M; Sugawara A; Mori K; Yahata K; Kasahara M; Suganami T; Makino H; Fujinaga Y; Yoshioka T; Tanaka I; Nakao K
Biochem Biophys Res Commun; 2000 Apr; 270(1):89-93. PubMed ID: 10733909
[TBL] [Abstract][Full Text] [Related]
47. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
48. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
Hay DL; Walker CS; Poyner DR
Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
[TBL] [Abstract][Full Text] [Related]
49. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
Roh J; Chang CL; Bhalla A; Klein C; Hsu SY
J Biol Chem; 2004 Feb; 279(8):7264-74. PubMed ID: 14615490
[TBL] [Abstract][Full Text] [Related]
50. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
51. Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells.
Aiyar N; Disa J; Pullen M; Nambi P
Mol Cell Biochem; 2001 Aug; 224(1-2):123-33. PubMed ID: 11693189
[TBL] [Abstract][Full Text] [Related]
52. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
53. Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin.
Uezono Y; Nakamura E; Ueda Y; Shibuya I; Ueta Y; Yokoo H; Yanagita T; Toyohira Y; Kobayashi H; Yanagihara N; Wada A
Brain Res Mol Brain Res; 2001 Dec; 97(1):59-69. PubMed ID: 11744163
[TBL] [Abstract][Full Text] [Related]
54. Calcitonin Gene Related Peptide, Adrenomedullin, and Adrenomedullin 2 Function in Uterine Artery During Human Pregnancy.
Chauhan M; Betancourt A; Balakrishnan M; Mishra A; Espinosa J; Shamshirsaz AA; Fox K; Belfort M; Yallampalli C
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34558598
[TBL] [Abstract][Full Text] [Related]
55. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
Aldecoa A; Gujer R; Fischer JA; Born W
FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
[TBL] [Abstract][Full Text] [Related]
56. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells.
Muff R; Leuthäuser K; Bühlmann N; Foord SM; Fischer JA; Born W
FEBS Lett; 1998 Dec; 441(3):366-8. PubMed ID: 9891972
[TBL] [Abstract][Full Text] [Related]
57. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
Nagoshi Y; Kuwasako K; Ito K; Uemura T; Kato J; Kitamura K; Eto T
Eur J Pharmacol; 2002 Aug; 450(3):237-43. PubMed ID: 12208315
[TBL] [Abstract][Full Text] [Related]
58. Adrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression.
Autelitano DJ; Ridings R
Peptides; 2001 Nov; 22(11):1851-7. PubMed ID: 11754972
[TBL] [Abstract][Full Text] [Related]
59. Phenotypic changes of adrenomedullin receptor components, RAMP2, and CRLR mRNA expression in cultured rat vascular smooth muscle cells.
Makino I; Honda K; Makino Y; Okano I; Kangawa K; Kamiya H; Shibata K; Kawarabayashi T
Biochem Biophys Res Commun; 2001 Nov; 288(3):515-20. PubMed ID: 11676473
[TBL] [Abstract][Full Text] [Related]
60. Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues.
Fukai N; Yoshimoto T; Sugiyama T; Ozawa N; Sato R; Shichiri M; Hirata Y
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E56-62. PubMed ID: 15315911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
